• 中文版
  • Home
  • About Us
    • Contract Research Organization
    • Contract Development and Manufacturing Organization
    • Accolades
    • Publications
  • Services Overview
  • Discovery Chemistry
    • Synthetic Chemistry
    • Medicinal Chemistry
    • Library Chemistry
    • Peptide Chemistry
    • Fragment Based Screening
    • Computer Aided Drug Design
    • Analytical Services
    • Protein Structure
  • Biology & Pharmacology
    • Oncology
    • Pathology Core Facility
    • Immunology
    • Tumor Immunology
    • Neuroscience
    • Cell Biology
    • In Vitro Biology
      • Kinases
      • Epigenetics
      • GPCR, NR, Ion-channel, Transporter
      • Ubiquitin & PROTAC
      • KRAS
      • COVID-19
      • Radiometric
      • Customized assay development
      • High throughput screening
      • MOA Study
    • Metabolic & Cardiovascular Diseases
  • DMPK / Exploratory Toxicology
    • DMPK / Exploratory Toxicology
    • Biomarkers, Preclinical & Clinical Sample Bioanalysis
    • Large molecule PK/BA services
  • Biologics Discovery
    • Antibody Discovery
    • Protein Science
    • Biologics Analytical Services
    • B Cell Cloning
  • Biologics CMC
    • Stable Cell Line Development
    • Process Development
    • Formulation Development
    • Aseptic Filling and Freeze-drying
    • Drug Developability / Manufacturability study
    • Final Container Extractables & Leachables Study
    • Analytical Development and Testing
    • GMP Production
  • Small Molecule CMC
    • Process R&D Services
    • Process Safety
    • Analytical Development
    • Pre-Formulation Development
    • Formulation Development
    • ICH Stability Studies
    • CMC CTD Support
    • Manufacturing
  • Blog
  • Careers
  • News & Events
    • Webinars
  • Contact Us
  • Download Center

Call us today! +86 21 5132 0088

contact@chempartner.com
中文版
Shanghai ChemPartner Shanghai ChemPartner Shanghai ChemPartnerShanghai ChemPartner
  • Home
  • About Us
    • About ChemPartner
    • CRO
    • CDMO
    • Accolades
    • Publications
  • Services
    • Discovery Chemistry
      • Synthetic Chemistry
      • Medicinal Chemistry
      • Library Chemistry
      • Peptide Chemistry
      • Fragment Based Screening
      • Computer Aided Drug Design
      • Analytical Services
      • Protein Structure
    • Biology & Pharmacology
      • Oncology
      • Pathology Core Facility
      • Immunology
      • Tumor Immunology
      • Cell Biology
      • In Vitro Biology
      • Neuroscience
      • Metabolic & Cardiovascular Diseases
      • Epigenetics
    • DMPK / Exploratory Toxicology
      • DMPK / Exploratory Toxicology
      • Biomarkers, Preclinical & Clinical Sample Bioanalysis
      • Large molecule PK/BA services
    • Biologics Discovery
      • Antibody Discovery
      • Protein Science
      • Biologics Analytical Services
      • B Cell Cloning
    • Biologics CMC
      • Stable Cell Line Development
      • Process Development
      • Formulation Development
      • Aseptic Filling and Freeze-drying
      • Drug Developability / Manufacturability study
      • Final Container Extractables & Leachables Study
      • Analytical Development and Testing
      • GMP Production
    • Small Molecule CMC
      • Process R&D Services
      • Process Safety
      • Analytical Development
      • Pre-Formulation Development
      • Formulation Development
      • ICH Stability Studies
      • CMC CTD Support
      • Manufacturing
  • Blog
  • Careers
  • News & Events
    • Webinars
  • Contact Us
  • Download Center

ChemPartner at the 18th Shanghai International Froum on Biotechnology & Pharmaceutical Industry

Jun 22, 2016 | Press Release |

The 18th International Forum on Biotechnology & Pharmaceutical Industry (Bio-Forum) was successfully held in Shanghai International

1-160622234212e7

Convention Center on June 20th-22nd, 2016.  Key themes of this conference revolves around the new technology and new development in the areas of novel drug development, clinical researches, biotechnology and pharmaceutical industry, as well as international technology transfer, transformation of sci-tech achievements and financial incentives. Meanwhile, some project promotion and exhibitions were carried out throughout this platform.

Over the past 10 years, Bio-Forum has evolved into an influential international conference in the area of biotechnology and pharmaceutical industry, which was always being supported by Ministry of Science & Technology of the P.R.C, State Food and Drug Administration, Science & Technology Commission of Shanghai Municipality, Shanghai Food and Drug Administration. This conference consists of different parts, including keynote speech, parallel sessions, partnering and exhibition, which attracted about 600 experts, scholars, entrepreneurs and government officials from home and abroad.

In the parallel session “Genetic Testing & Precision Medicine” on the afternoon of June 21st, Dr. Jason Xiang, Vice President at Shanghai ChemPartner, delivered an exciting speech on “ADC Site-Specific Conjugation Technology”. ChemPartner is amongst the largest and most experienced Chemistry Service Organizations in China, which excels at MedChem design, custom synthesis, library synthesis, as well as peptide, nucleoside and natural product chemistry.

1-16062223414e28

With a force of nearly 1000 Synthetic and Medicinal Chemists, ChemPartner has access to state-of-the-art instrumentation, modeling, property prediction and structure based design tools, including a comprehensive suite of commercial software for every stage of discovery, analytical (including chiral separation), compound and project management support. Except Zhangjiang site, ChemPartner also has sophisticated labs in Chengdu and San Francisco, and has experience in driving our clients’ projects independently for virtual companies, co-piloting with our clients’ in-house experts and providing extensive and effective chemistry services. The Medchemists also worked closely with the biologists and DMPK colleagues to deliver on multiple preclinical integrated projects that yielded multiple clinical candidates for clients.

Tags: ChemPartnerShanghai
1
Share

You also might be interested in

Shanghai ChemPartner Sponsors Peptide Therapeutic Foundation(PTF)

Oct 25, 2017

Shanghai, China (October 25, 2017) – Shanghai ChemPartner today announced[...]

Berkeley Lights and ChemPartner Collaborate on Accelerating Antibody Discovery

Jun 28, 2018

EMERYVILLE, Calif., June 27, 2018 /PRNewswire/ — Berkeley Lights, Inc. (BLI), a leader[...]

ChemPartner at PEGS 2016 in Boston

ChemPartner at PEGS 2016 in Boston

May 4, 2016

The 12th Annual PEGS (Protein & Antibody Engineering and Development[...]

Latest News

ChemPartner Makes Additional Investments in Biologics from Research to Manufacturing Capabilities

06/11/2020

Shanghai, China (June 9, 2020) – Shanghai ChemPartner...

ChemPartner Assists the Mount Sinai Health System in Producing Reagent for COVID-19 Research

05/12/2020

Shanghai, China (May 12, 2020) – Shanghai ChemPartner...

ChemPartner and the Gladstone Institutes Announce COVID-19 Research Collaboration

04/17/2020

SAN FRANCISCO, Calif. and SHANGHAI, China. (April 15, 2020)...

ChemPartner Introduces New State-of-the-Art Global Operation Center in Shanghai

04/02/2020

Shanghai, China (March 17, 2020) – Shanghai ChemPartner...

Dr. Jie Jack Li joins Shanghai ChemPartner as a Vice President of Discovery Chemistry

12/18/2019

Shanghai, China (December 17, 2019) – Shanghai ChemPartner...

Shanghai ChemPartner was awarded “TOP 10 CMOs in 2019”

Shanghai ChemPartner was awarded “TOP 10 CMOs in 2019”

07/19/2019

Contract manufacturers play a significant role when it comes...

Tag Cloud

2017 AACR Agreement Antibody Engineering art Berkeley Lights Best Life Science BIOtech Blend Boston Capital Market Chemistry ChemPartner Congratulates CPhI CPSA Shanghai 2016 CRO DMPK Exploratory Toxicology Labs layout Merger Deal PEGS PEGS CHINA Peptide Pharma Pharmacology product PTF Qidong Quantum Hi-Tech China Biological Research Facility San Diego San Francisco Shanghai Shanghai ChemPartner ShangPharma Sponsor Strategic Corporate Restructuring Tarveda Therapeutic Top 10 CMOs Vice President World ADC

Give us a Message

You can leave us a message by quick contact box and we'll get back to you, asap. Thanks!

Send Message

Logo

ChemPartner is a leading research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry.

Get started today.

Contact Us
  • Shanghai ChemPartner Co., Ltd.
  • 1F & 3F, Block A, 2829 JinKe Road, Zhangjiang Hi-Tech Park, PuDong New Area, Shanghai China, 201203
  • +86 21 5132 0088
  • contact@chempartner.com

© 2021 — Shanghai ChemPartner Co., Ltd. All Rights Reserved  About Us  Careers  Contact Us  Privacy Policy  Sitemap

  • Home
  • Contact
  • Buy Highend
Prev Next